Basic cytokeratin inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of basic cytokeratins, which are a subset of the cytokeratin family of intermediate filament proteins. Cytokeratins are essential structural components of the cytoskeleton in epithelial cells, providing mechanical support and contributing to the maintenance of cellular integrity. Basic cytokeratins, classified as type II cytokeratins, are typically paired with acidic (type I) cytokeratins to form stable heterodimers that assemble into intermediate filaments. These filaments are crucial for maintaining cell shape, enabling cellular resilience against mechanical stress, and facilitating various cellular processes such as intracellular transport and cell division. By inhibiting basic cytokeratins, researchers can disrupt these structural functions and study the resulting impacts on cellular behavior and tissue architecture.
In research, basic cytokeratin inhibitors serve as important tools for understanding the role of intermediate filaments in epithelial cell biology. By blocking the function of basic cytokeratins, scientists can investigate how the disruption of cytoskeletal integrity affects cell morphology, adhesion, and motility. This is particularly relevant in the context of understanding how epithelial tissues respond to mechanical forces and how the cytoskeleton contributes to cellular organization and function. Additionally, the inhibition of basic cytokeratins allows researchers to explore the protein-protein interactions within the cytoskeletal network and how these interactions influence signaling pathways that regulate cell growth, differentiation, and apoptosis. By using basic cytokeratin inhibitors, researchers can gain deeper insights into the molecular mechanisms that govern cytoskeletal dynamics, the maintenance of epithelial tissue structure, and the broader implications of intermediate filament function in cellular homeostasis and tissue development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
A tyrosine kinase inhibitor that can indirectly affect cytokeratin expression by altering growth factor signaling in epithelial cells. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Similar to gefitinib, erlotinib targets epidermal growth factor receptor (EGFR) and can influence cytokeratin expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase, Trichostatin A can modify gene expression, potentially affecting cytokeratin levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to modulate various signaling pathways, potentially influencing cytokeratin expression in epithelial cells. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
A histone deacetylase inhibitor that can affect gene expression, including genes related to cytokeratin production. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
While primarily an immunosuppressant, cyclosporine A can influence cellular pathways affecting cytokeratin expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
An antimetabolite and antifolate drug, methotrexate can impact cell proliferation and differentiation, affecting cytokeratin levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, rapamycin can affect protein synthesis and cell growth, potentially impacting cytokeratin expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can influence various cellular pathways, including those regulating cytokeratin expression. | ||||||